Enveric Biosciences (ENVB) Selling, General & Administrative (2010 - 2026)
Enveric Biosciences (ENVB) posted Selling, General & Administrative of $1.64 million for Q2 2026, up 34.2% from $1.22 million a year earlier and up 30.8% from the prior quarter.
Powered by 
Analysis
Enveric Biosciences (ENVB) Selling, General & Administrative (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Enveric Biosciences was $6.1 million, up 3.4% year-over-year; for FY2025, it came in at $5.79 million, down 10.2% from FY2024.
- Annual Selling, General & Administrative has declined for four consecutive years, though with a five-year compound annual growth rate of 1.7% (FY2020 to FY2025).
- In prior years, Enveric Biosciences' Selling, General & Administrative was $6.45 million in FY2024 (-27.1%), $8.85 million in FY2023 (-23.7%), $11.61 million in FY2022 (-43.4%) and $20.5 million in FY2021 (+285.1%).
- Quarterly Selling, General & Administrative has run from a low of $578,677 in Q4 2023 to a high of $9.63 million in Q4 2021 over five years.
- On a year-over-year basis, Selling, General & Administrative increased in three of the last eight quarters, with growth averaging 28.0%.
- The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q3 2021, with growth of 397.9%; the weakest was Q4 2023, with a decline of 79.5%.
- According to Business Quant data, Selling, General & Administrative for the three prior quarters was $1.25 million (Q1 2026), $1.78 million (Q4 2025) and $1.43 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 6.43 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.63 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.90 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -3.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -5.65 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.75 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.92 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 3.41 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 582.20 Mn |
| 10 | Enveric Biosciences | 5.86 Mn | -15.78 Mn | - | 1.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.64 Mn |
| Mar 31, 2026 | 1.25 Mn |
| Dec 31, 2025 | 1.78 Mn |
| Sep 30, 2025 | 1.43 Mn |
| Jun 30, 2025 | 1.22 Mn |
| Mar 31, 2025 | 1.36 Mn |
| Dec 31, 2024 | 2.12 Mn |
| Sep 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | 1.25 Mn |
| Mar 31, 2024 | 1.89 Mn |
| Dec 31, 2023 | 578,677.00 |
| Sep 30, 2023 | 2.08 Mn |
| Jun 30, 2023 | 3.27 Mn |
| Mar 31, 2023 | 2.95 Mn |
| Dec 31, 2022 | 2.82 Mn |
| Sep 30, 2022 | 3.51 Mn |
| Jun 30, 2022 | 2.50 Mn |
| Mar 31, 2022 | 2.77 Mn |
| Dec 31, 2021 | 9.63 Mn |
| Sep 30, 2021 | 2.12 Mn |
API Access
Enveric Biosciences Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ENVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "ENVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ENVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();